Hualan Biological Engineering Statistics

Total Valuation

Hualan Biological Engineering has a market cap or net worth of CNY 29.41 billion. The enterprise value is 29.56 billion.

Market Cap	29.41B
Enterprise Value	29.56B

Important Dates

The next estimated earnings date is Saturday, March 29, 2025.

Earnings Date	Mar 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Hualan Biological Engineering has 1.83 billion shares outstanding. The number of shares has increased by 0.21% in one year.

Current Share Class	n/a
Shares Outstanding	1.83B
Shares Change (YoY)	+0.21%
Shares Change (QoQ)	-0.69%
Owned by Insiders (%)	18.46%
Owned by Institutions (%)	11.97%
Float	963.35M

Valuation Ratios

The trailing PE ratio is 21.99 and the forward PE ratio is 18.48. Hualan Biological Engineering's PEG ratio is 1.45.

PE Ratio	21.99
Forward PE	18.48
PS Ratio	5.97
PB Ratio	2.51
P/TBV Ratio	2.58
P/FCF Ratio	67.44
P/OCF Ratio	n/a
PEG Ratio	1.45

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.85, with an EV/FCF ratio of 67.79.

EV / Earnings	22.09
EV / Sales	6.01
EV / EBITDA	16.85
EV / EBIT	19.64
EV / FCF	67.79

Financial Position

The company has a current ratio of 4.05, with a Debt / Equity ratio of 0.06.

Current Ratio	4.05
Quick Ratio	2.25
Debt / Equity	0.06
Debt / EBITDA	0.43
Debt / FCF	1.74
Interest Coverage	98.69

Financial Efficiency

Return on equity (ROE) is 11.27% and return on invested capital (ROIC) is 6.65%.

Return on Equity (ROE)	11.27%
Return on Assets (ROA)	5.95%
Return on Capital (ROIC)	6.65%
Revenue Per Employee	1.33M
Profits Per Employee	360,731
Employee Count	3,709
Asset Turnover	0.31
Inventory Turnover	1.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.89% in the last 52 weeks. The beta is 0.34, so Hualan Biological Engineering's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	-19.89%
50-Day Moving Average	17.05
200-Day Moving Average	17.18
Relative Strength Index (RSI)	34.77
Average Volume (20 Days)	12,634,103

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hualan Biological Engineering had revenue of CNY 4.92 billion and earned 1.34 billion in profits. Earnings per share was 0.73.

Revenue	4.92B
Gross Profit	3.05B
Operating Income	1.51B
Pretax Income	1.73B
Net Income	1.34B
EBITDA	1.75B
EBIT	1.51B
Earnings Per Share (EPS)	0.73

Full Income Statement

Balance Sheet

The company has 2.62 billion in cash and 759.43 million in debt, giving a net cash position of 1.86 billion or 1.02 per share.

Cash & Cash Equivalents	2.62B
Total Debt	759.43M
Net Cash	1.86B
Net Cash Per Share	1.02
Equity (Book Value)	13.71B
Book Value Per Share	6.40
Working Capital	6.98B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.11 billion and capital expenditures -676.88 million, giving a free cash flow of 436.05 million.

Operating Cash Flow	1.11B
Capital Expenditures	-676.88M
Free Cash Flow	436.05M
FCF Per Share	0.24

Full Cash Flow Statement

Margins

Gross margin is 61.92%, with operating and profit margins of 30.60% and 27.20%.

Gross Margin	61.92%
Operating Margin	30.60%
Pretax Margin	35.08%
Profit Margin	27.20%
EBITDA Margin	35.65%
EBIT Margin	30.60%
FCF Margin	8.86%

Dividends & Yields

This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 1.87%.

Dividend Per Share	0.30
Dividend Yield	1.87%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	35.41%
Buyback Yield	-0.21%
Shareholder Yield	1.65%
Earnings Yield	4.55%
FCF Yield	1.48%

Dividend Details

Stock Splits

The last stock split was on April 27, 2020. It was a forward split with a ratio of 1.3.

Last Split Date	Apr 27, 2020
Split Type	Forward
Split Ratio	1.3

Scores

Hualan Biological Engineering has an Altman Z-Score of 10.62.

Altman Z-Score	10.62
Piotroski F-Score	n/a